Effects of suggestion therapy on mood and sleep quality in middle-aged women with depression.

IF 3.9 4区 医学 Q1 PSYCHIATRY
Yuan Jiang, Ke-Ke Xia, Zhi-Yuan Lin
{"title":"Effects of suggestion therapy on mood and sleep quality in middle-aged women with depression.","authors":"Yuan Jiang, Ke-Ke Xia, Zhi-Yuan Lin","doi":"10.5498/wjp.v15.i3.100009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Depression is one of the most common mental disorders, with high rates of disability, particularly among women.</p><p><strong>Aim: </strong>To explore the effects of suggestion therapy on anxiety, mood, and sleep-quality in middle-aged women with depression treated with escitalopram.</p><p><strong>Methods: </strong>Overall, 102 female patients with depression aged 35-49 years were divided into control and experimental groups. The control group received oral escitalopram therapy, starting at a dose of 5 mg/day, which was gradually increased to 10-20 mg/day after 1 week for a total of 8 weeks. The experimental group received the suggested therapy based on the control group. The Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Profile of Mood States-Short Form, and Pittsburgh Sleep Quality Index (PSQI) were used to assess depression, anxiety, mood status, and sleep quality.</p><p><strong>Results: </strong>Before treatment, there were no significant differences in the SDS, SAS, Profile of Mood States, and PSQI scores between the two groups (<i>P</i> > 0.05). After treatment, compared to the control group and baseline, the SDS, SAS, tension-anxiety, depression-dejection, and confusion-bewilderment scores in the experimental group significantly decreased (<i>P</i> < 0.05), whereas sleep efficiency, sleep disturbance, hypnotics, and PSQI scores significantly increased (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Suggestion therapy combined with escitalopram treatment can reduce the severity of depression and anxiety, change mood status, and improve sleep quality in middle-aged women with depression.</p>","PeriodicalId":23896,"journal":{"name":"World Journal of Psychiatry","volume":"15 3","pages":"100009"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886323/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5498/wjp.v15.i3.100009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Depression is one of the most common mental disorders, with high rates of disability, particularly among women.

Aim: To explore the effects of suggestion therapy on anxiety, mood, and sleep-quality in middle-aged women with depression treated with escitalopram.

Methods: Overall, 102 female patients with depression aged 35-49 years were divided into control and experimental groups. The control group received oral escitalopram therapy, starting at a dose of 5 mg/day, which was gradually increased to 10-20 mg/day after 1 week for a total of 8 weeks. The experimental group received the suggested therapy based on the control group. The Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Profile of Mood States-Short Form, and Pittsburgh Sleep Quality Index (PSQI) were used to assess depression, anxiety, mood status, and sleep quality.

Results: Before treatment, there were no significant differences in the SDS, SAS, Profile of Mood States, and PSQI scores between the two groups (P > 0.05). After treatment, compared to the control group and baseline, the SDS, SAS, tension-anxiety, depression-dejection, and confusion-bewilderment scores in the experimental group significantly decreased (P < 0.05), whereas sleep efficiency, sleep disturbance, hypnotics, and PSQI scores significantly increased (P < 0.05).

Conclusion: Suggestion therapy combined with escitalopram treatment can reduce the severity of depression and anxiety, change mood status, and improve sleep quality in middle-aged women with depression.

暗示疗法对中年女性抑郁症患者情绪及睡眠质量的影响。
背景:抑郁症是最常见的精神障碍之一,残疾率很高,尤其是在女性中。目的:探讨暗示疗法对艾司西酞普兰治疗的中年女性抑郁症患者焦虑、情绪和睡眠质量的影响。方法:将102例35 ~ 49岁女性抑郁症患者分为对照组和实验组。对照组给予口服艾司西酞普兰治疗,起始剂量为5mg /天,1周后逐渐增加至10- 20mg /天,共8周。实验组在对照组的基础上接受建议治疗。采用抑郁自评量表(SDS)、焦虑自评量表(SAS)、情绪状态简表和匹兹堡睡眠质量指数(PSQI)评估抑郁、焦虑、情绪状态和睡眠质量。结果:治疗前,两组患者SDS、SAS、心境状态谱、PSQI评分比较,差异均无统计学意义(P < 0.05)。治疗后,与对照组和基线比较,实验组SDS、SAS、紧张焦虑、抑郁抑郁、困惑困惑评分显著降低(P < 0.05),睡眠效率、睡眠障碍、催眠剂、PSQI评分显著升高(P < 0.05)。结论:暗示疗法联合艾司西酞普兰治疗可减轻中年女性抑郁症患者抑郁、焦虑程度,改变情绪状态,改善睡眠质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
6.50%
发文量
110
期刊介绍: The World Journal of Psychiatry (WJP) is a high-quality, peer reviewed, open-access journal. The primary task of WJP is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of psychiatry. In order to promote productive academic communication, the peer review process for the WJP is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJP are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信